| Ticker Details |
Amgen Inc.
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$237.52B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.68 | 1.12%
|
| Avg Daily Range (30 D): |
$5.28 | 1.35%
|
| Avg Daily Range (90 D): |
$4.29 | 1.19%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
4.71M |
| Avg Daily Volume (30 D): |
1.74M |
| Avg Daily Volume (90 D): |
1.8M |
| Trade Size |
| Avg Trade Size (Sh.): |
126 |
| Avg Trade Size (Sh.) (30 D): |
30 |
| Avg Trade Size (Sh.) (90 D): |
31 |
| Institutional Trades |
| Total Institutional Trades: |
115,714 |
| Avg Institutional Trade: |
$6.82M |
| Avg Institutional Trade (30 D): |
$44.6M |
| Avg Institutional Trade (90 D): |
$42.79M |
| Avg Institutional Trade Volume: |
.06M |
| Avg Institutional Trades (Per Day): |
20 |
| Market Closing Trades |
| Avg Closing Trade: |
$71.19M |
| Avg Closing Trade (30 D): |
$216.61M |
| Avg Closing Trade (90 D): |
$224.01M |
| Avg Closing Volume: |
396.99K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$16.22
|
$4.4
|
$3.37
|
|
Diluted EPS
|
$16.1
|
$4.37
|
$3.34
|
|
Revenue
|
$38.1B
|
$10.05B
|
$8.62B
|
|
Gross Profit
|
$26.48B
|
$7.24B
|
$5.87B
|
|
Net Income / Loss
|
$8.74B
|
$2.38B
|
$1.82B
|
|
Operating Income / Loss
|
$11.43B
|
$3.51B
|
$2.67B
|
|
Cost of Revenue
|
$11.61B
|
$2.81B
|
$2.74B
|
|
Net Cash Flow
|
$5.96B
|
$1.95B
|
$2.91B
|
|
PE Ratio
|
|
|
|
|
|
|
